Crown Bioscience, founded in 2006, is a global contract research organization (CRO) focused on oncology and immune-related diseases. They provide preclinical models, including tumor organoids and a vast PDX collection. Services cover imaging, 3D tissues, and biomarker analysis, partnering to enhance drug candidates for personalized therapies.
